ResearcherThe University of OsakaNo recent work listed
Shohei Takaichi
Matched on ORCID iD 0000-0002-7398-4093; OpenAlex author ID A5050438711. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2023: 2 papers
Papers 2
- Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma U… Co-author DOI 10.1245/s10434-022-12985-0↗
- ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancre… Co-author DOI 10.1245/s10434-022-13024-8↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masahiro Tanemura · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Tadafumi Asaoka · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Yuichiro Doki · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Yoshifumi Iwagami · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Hidetoshi Eguchi · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Keisuke Toya · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Yoshito Tomimaru · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Daisaku Yamada · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Hidenori Takahashi · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
- Kazuki Sasaki · 2 shared papers, 2023 · strength 0.32
- Paper Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resec… DOI 10.1245/s10434-022-12985-0↗
- Paper ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic… DOI 10.1245/s10434-022-13024-8↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.